FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like Georgia's Visioneering Technologies Successfully Snags $33.3 Million IPO March 15, 2017 22nd Century Group, Inc. Issues Annual Letter To Shareholders March 20, 2017 <b>J.P. Morgan</b>???s <b>Commercial Bank</b> Expands Life Sciences Team To Serve Fast-Growing Industry Team Adds Experienced Bankers And Expands To Key U.S. Markets July 26, 2017
<b>J.P. Morgan</b>???s <b>Commercial Bank</b> Expands Life Sciences Team To Serve Fast-Growing Industry Team Adds Experienced Bankers And Expands To Key U.S. Markets July 26, 2017
